CLO25-063: Immune Checkpoint Inhibitor Therapy and the Risk of Second Primary Malignancies in Melanoma and Lung Cancer Patients. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

CLO25-063: Immune Checkpoint Inhibitor Therapy and the Risk of Second Primary Malignancies in Melanoma and Lung Cancer Patients.

Muntaser Al Zyoud, Osama M Younis, Muhammad Awidi

Author Information

Muntaser Al Zyoud: 1School of Medicine, University of Jordan, Amman, Jordan.
Osama M Younis: 1School of Medicine, University of Jordan, Amman, Jordan.
Muhammad Awidi: 2Roswell Park Comprehensive Cancer Center, Buffalo, NY.

PMID: 40159151 DOI: 10.6004/jnccn.2024.7144

No abstract text available.

Journal Article

No available data.